Cymbalta, the drug manufactured by Eli Lilly is now legally approved to be marketed in Europe.
The drug is used as treatment for generalized anxiety disorder where the victim experiences a great deal of worry and anxiety. Anxiety disorder is known to afflict 9 million people in Europe.
Agoraphobia
Agoraphobia is an anxiety disorder characterised by the patient avoiding spaces, crowds, or situations
Advertisement
The drug had earlier been approved for use to alleviate severe depressive disorder and neuropathic pain.
For instance, in the United States, the drug was used to treat anxiety diabetic nerve pain, major depressive disorder and fibromyalgia.
Sales for this drug had touched $2.1 billion in 2007. Shares of Eli Lilly has shown progress, up by 1.7%.
Source: Medindia
SAV
Sales for this drug had touched $2.1 billion in 2007. Shares of Eli Lilly has shown progress, up by 1.7%.
Source: Medindia
SAV
Circadian Rhythm Sleep Disorders
Circadian rhythm (also known as sleep/wake cycle or the body clock) is a biological process that follows an internal cycle of roughly 24 hours.
Advertisement
Advertisement
|
Advertisement
Latest Drug News
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.